Wuhan Pulmonary Hospital，Wuhan Tuberculosis Prevention and Control Institute
Welcome,         Profile    Billing    Logout  
 3 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Zhihui
NCT04766307: A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2

Recruiting
4
1100
RoW
Interleukin-2, IL-2
Beijing Chest Hospital
Tuberculosis, Pulmonary
12/21
12/21
NCT04908865: Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)

Active, not recruiting
4
67
RoW
Belimumab, Standard therapy
GlaxoSmithKline
Systemic Lupus Erythematosus
05/24
09/24
NCT05772871: The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children

Recruiting
4
402
RoW
Huaiqihuang granule, Prednisone, Levamisole placebo, Levamisole, Huaiqihuang Granule placebo
Jianhua Zhou, LinkDoc Technology (Beijing) Co. Ltd.
Nephrotic Syndrome in Children
09/25
10/25
INSPIRE-BDLL, NCT06649721: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort

Not yet recruiting
3
120
RoW
bedaquiline, BDQ, B, delamanid, DLM, D, linezolid, LZD, L, Levofloxacin, LFX, Clofazimine, CFZ, C
Huashan Hospital, Beijing Chest Hospital
Drug-resistant Tuberculosis, Pulmonary Tuberculosis, Rifampin-resistant Tuberculosis
06/27
06/27
INSPIRE-CODA, NCT06081361: Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort

Recruiting
3
186
RoW
Bedaquiline, BDQ, Delamanid, DLM, Contezolid, CZD, Levofloxacin, LFX, Moxifloxacin, MFX, Clofazimine, CFZ, Linezolid, LZD, Cycloserine, CS, Prothionamide, Pto, Pyrazinamide, PZA, Para-Aminosalicylic Acid, PAS, Ethambutol, EMB
Beijing Chest Hospital, National Medical Center for Infectious Diseases
Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
10/26
12/26
NCT06482086: Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

Recruiting
2
75
RoW
Anlotinib, Lenvatinib, Sorafenib, Donafenib, Everolimus, Apatinib, Dabrafenib + Trametinib, Cabozantinib, Vandetanib, Entrectinib, Pralsetinib, Larotrectinib
West China Hospital
Locally Advanced Thyroid Gland Carcinoma
12/24
12/25
NCT06713057: Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

Not yet recruiting
2
20
RoW
Cyclophosphamide+Pemetrexed+5-Fluorouracil, Cyclophosphamide+Doxorubicin+5-Fluorouracil, Vindesine + Cisplatin, Doxorubicin + Cisplatin, Doxorubicin + Cyclophosphamide + Cisplatin, Docetaxel + Doxorubicin, Paclitaxel + Carboplatin, Paclitaxel + Doxorubicin, Paclitaxel + Cisplatin, Gemcitabine alone
West China Hospital
Locally Advanced Thyroid Gland Carcinoma, Thyroid Cancer
12/25
07/26
NCT06446180: Streptococcus Salivarius K12@Lip@GSH Alleviates Oral Mucositis in Patients Undergoing Radiotherapy

Completed
N/A
20
RoW
SsK12@Lip@GSH
The General Hospital of Western Theater Command
Oral Mucositis
03/24
05/24
NCT05925452: To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.

Recruiting
N/A
221
RoW
GenaKumab
Changchun GeneScience Pharmaceutical Co., Ltd.
Active Systemic Juvenile Idiopathic Arthritis
03/28
06/28

Download Options